Annual Accounts Receivable
$76.78 M
+$27.15 M+54.70%
December 31, 2023
Summary
- As of February 7, 2025, ASTH annual accounts receivable is $76.78 million, with the most recent change of +$27.15 million (+54.70%) on December 31, 2023.
- During the last 3 years, ASTH annual accounts receivable has risen by +$69.72 million (+987.84%).
- ASTH annual accounts receivable is now at all-time high.
Performance
ASTH Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$132.24 M
-$86.00 K-0.06%
September 30, 2024
Summary
- As of February 7, 2025, ASTH quarterly accounts receivable is $132.24 million, with the most recent change of -$86.00 thousand (-0.06%) on September 30, 2024.
- Over the past year, ASTH quarterly accounts receivable has increased by +$12.13 million (+10.10%).
- ASTH quarterly accounts receivable is now -0.06% below its all-time high of $132.32 million, reached on June 30, 2024.
Performance
ASTH Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
ASTH Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +54.7% | +10.1% |
| 3 y3 years | +987.8% | +10.1% |
| 5 y5 years | +892.7% | +10.1% |
ASTH Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +623.8% | -0.1% | +1146.6% |
| 5 y | 5-year | at high | +987.8% | -0.1% | +1773.6% |
| alltime | all time | at high | >+9999.0% | -0.1% | >+9999.0% |
Astrana Health Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $132.24 M(-0.1%) |
| Jun 2024 | - | $132.32 M(+10.2%) |
| Mar 2024 | - | $120.11 M(+56.4%) |
| Dec 2023 | $76.78 M(+54.7%) | $76.78 M(-19.9%) |
| Sep 2023 | - | $95.89 M(+43.3%) |
| Jun 2023 | - | $66.93 M(-15.3%) |
| Mar 2023 | - | $79.00 M(+59.2%) |
| Dec 2022 | $49.63 M(+367.9%) | - |
| Dec 2022 | - | $49.63 M(-28.5%) |
| Sep 2022 | - | $69.39 M(+3.2%) |
| Jun 2022 | - | $67.26 M(+21.7%) |
| Mar 2022 | - | $55.28 M(+421.1%) |
| Dec 2021 | $10.61 M(+50.3%) | $10.61 M(-43.4%) |
| Sep 2021 | - | $18.75 M(+13.4%) |
| Jun 2021 | - | $16.54 M(+0.6%) |
| Mar 2021 | - | $16.45 M(+133.0%) |
| Dec 2020 | $7.06 M(-35.9%) | $7.06 M(-61.3%) |
| Sep 2020 | - | $18.26 M(+3.8%) |
| Jun 2020 | - | $17.59 M(-2.4%) |
| Mar 2020 | - | $18.01 M(+63.7%) |
| Dec 2019 | $11.00 M(+42.3%) | $11.00 M(-44.2%) |
| Sep 2019 | - | $19.73 M(+18.1%) |
| Jun 2019 | - | $16.71 M(+151.6%) |
| Mar 2019 | - | $6.64 M(-14.1%) |
| Dec 2018 | $7.73 M(+1.7%) | $7.73 M(-89.0%) |
| Sep 2018 | - | $70.08 M(+102.9%) |
| Jun 2018 | - | $34.54 M(-34.6%) |
| Mar 2018 | - | $52.81 M(+987.2%) |
| Dec 2017 | $7.60 M(+38.1%) | - |
| Sep 2017 | - | $4.86 M(-10.4%) |
| Jun 2017 | - | $5.42 M(-1.5%) |
| Mar 2017 | $5.51 M | $5.51 M(-8.0%) |
| Dec 2016 | - | $5.99 M(+30.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2016 | - | $4.58 M(+14.5%) |
| Jun 2016 | - | $4.00 M(+17.9%) |
| Mar 2016 | $3.39 M(-10.8%) | $3.39 M(-7.2%) |
| Dec 2015 | - | $3.65 M(-9.0%) |
| Sep 2015 | - | $4.02 M(+8.7%) |
| Jun 2015 | - | $3.69 M(-2.9%) |
| Mar 2015 | $3.80 M(+152.0%) | $3.80 M(+8.4%) |
| Dec 2014 | - | $3.51 M(+4.1%) |
| Sep 2014 | - | $3.37 M(+120.0%) |
| Jun 2014 | - | $1.53 M(+1.4%) |
| Mar 2014 | $1.51 M(-0.1%) | - |
| Jan 2014 | $1.51 M(-4.6%) | $1.51 M(+2.3%) |
| Oct 2013 | - | $1.48 M(+3.5%) |
| Jul 2013 | - | $1.43 M(+8.0%) |
| Apr 2013 | - | $1.32 M(-16.6%) |
| Jan 2013 | $1.58 M(+59.2%) | $1.58 M(+19.6%) |
| Oct 2012 | - | $1.32 M(+32.6%) |
| Jul 2012 | - | $998.30 K(-12.9%) |
| Apr 2012 | - | $1.15 M(+15.3%) |
| Jan 2012 | $994.10 K(+41.0%) | $994.10 K(+12.3%) |
| Oct 2011 | - | $885.20 K(+24.9%) |
| Jul 2011 | - | $708.60 K(+2.3%) |
| Apr 2011 | - | $692.40 K(-1.8%) |
| Jan 2011 | $705.00 K(+54.1%) | $705.00 K(+9.6%) |
| Oct 2010 | - | $643.10 K(+3.3%) |
| Jul 2010 | - | $622.70 K(-4.7%) |
| Apr 2010 | - | $653.70 K(+42.9%) |
| Jan 2010 | $457.50 K(+78.9%) | $457.50 K(+9.8%) |
| Oct 2009 | - | $416.60 K(+25.9%) |
| Jul 2009 | - | $331.00 K(+23.0%) |
| Apr 2009 | - | $269.20 K(+5.3%) |
| Jan 2009 | $255.70 K | $255.70 K(+69.4%) |
| Oct 2008 | - | $150.90 K |
FAQ
- What is Astrana Health annual accounts receivable?
- What is the all time high annual accounts receivable for Astrana Health?
- What is Astrana Health annual accounts receivable year-on-year change?
- What is Astrana Health quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Astrana Health?
- What is Astrana Health quarterly accounts receivable year-on-year change?
What is Astrana Health annual accounts receivable?
The current annual accounts receivable of ASTH is $76.78 M
What is the all time high annual accounts receivable for Astrana Health?
Astrana Health all-time high annual accounts receivable is $76.78 M
What is Astrana Health annual accounts receivable year-on-year change?
Over the past year, ASTH annual accounts receivable has changed by +$27.15 M (+54.70%)
What is Astrana Health quarterly accounts receivable?
The current quarterly accounts receivable of ASTH is $132.24 M
What is the all time high quarterly accounts receivable for Astrana Health?
Astrana Health all-time high quarterly accounts receivable is $132.32 M
What is Astrana Health quarterly accounts receivable year-on-year change?
Over the past year, ASTH quarterly accounts receivable has changed by +$12.13 M (+10.10%)